Stem cell trials focus on fixing hearts

03/22/2007 | MIT Technology Review

Studies have offered mixed results on the benefits of stem cell therapy to treat heart disease, pointing out that to be effective there needs to be knowledge of which cells to transplant and when and how to prepare and deliver them. In a new trial focusing on patients who've not responded to other treatment, a specific blood-forming stem cell will be injected directly into the heart. One expert said that learning how to heal a damaged heart "could revolutionize cardiology."

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL